The federal government has set an ambitious goal of increasing Pakistan’s pharmaceutical exports to 30 billion dollars within the next five years, as part of a broader plan to strengthen the country’s economy and global trade footprint.
The target was discussed during a high-level meeting of the Drug Regulatory Authority of Pakistan (DRAP), chaired by Federal Health Minister Mustafa Kamal. The meeting was attended by the Federal Secretary for Health, Additional Secretary, and the Chief Executive Officer of DRAP.
Officials reviewed progress on the five-year export strategy, with the minister emphasizing the government’s firm commitment to expanding Pakistan’s pharmaceutical exports.
“We are determined to boost the export of locally produced medicines,” Kamal said, adding that all possible measures are being taken to achieve the set targets. “The Ministry of Health and DRAP teams are closely monitoring the progress of this plan.”
He stressed that ensuring access for Pakistani medicines to major global trading blocs is a top priority. Necessary regulatory, quality, and trade facilitation steps are being implemented to meet international standards.
“This plan is not merely a numerical target but a symbol of Pakistan’s economic resilience,” the minister noted. “By transforming the pharmaceutical sector into a strong export-driven industry, we aim to reinforce the national economy.”
Kamal added that regular follow-up meetings will be held to maintain oversight and ensure sustained progress on the initiative.
